glatiramer acetate

FDA Drug Profile — GLATIRAMER ACETATE, Glatiramer Acetate

Drug Details

Generic Name
glatiramer acetate
Brand Names
GLATIRAMER ACETATE, Glatiramer Acetate
Application Number
ANDA208468
Sponsor
Italfarmaco SpA
NDC Codes
7
Dosage Forms
INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients
GLATIRAMER ACETATE

Indications and Usage

1 INDICATIONS AND USAGE Glatiramer Acetate Injection is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Glatiramer Acetate Injection is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults ( 1 ).